0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global OPO-containing Infant Formulas Market Research Report 2026
Published Date: 2026-01-22
|
Report Code: QYRE-Auto-34R18527
Home | Market Reports | Food & Drink| Food
Global OPO containing Infant Formulas Market Research Report 2024
BUY CHAPTERS

Global OPO-containing Infant Formulas Market Research Report 2026

Code: QYRE-Auto-34R18527
Report
2026-01-22
Pages:125
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

OPO-containing Infant Formulas Market Size

The global OPO-containing Infant Formulas market was valued at US$ 1117 million in 2025 and is anticipated to reach US$ 1564 million by 2032, at a CAGR of 5.0% from 2026 to 2032.

OPO-containing Infant Formulas Market

OPO-containing Infant Formulas Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on OPO-containing Infant Formulas competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
OPO-containing infant formulas are specialized formulas enriched with structured triglycerides, predominantly 1,3-dioleoyl-2-palmitoylglycerol (OPO), designed to mimic the fat structure of human breast milk. OPO enhances the bioavailability of palmitic acid in a way that promotes better fat and calcium absorption, reducing the risk of constipation and improving stool consistency in infants. Key features include a balanced lipid profile, enhanced digestibility, and a role in supporting gut health by fostering beneficial microbiota. These formulas are particularly beneficial for infants who cannot be breastfed, offering improved energy utilization, growth support, and comfort in digestion, making them suitable for addressing feeding issues and ensuring optimal nutrient uptake.
The North American market for OPO-containing Infant Formulas is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for OPO-containing Infant Formulas is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of OPO-containing Infant Formulas include BiosTime, Nutriben, Ausnutria, HERDS, Milupa, Shanxi Yatai, Beingmate, Abbott, Brightdairy, Feihe, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global OPO-containing Infant Formulas market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding OPO-containing Infant Formulas. The OPO-containing Infant Formulas market size, estimates, and forecasts are provided in terms of sales volume (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global OPO-containing Infant Formulas market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist OPO-containing Infant Formulas manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of OPO-containing Infant Formulas Market Report

Report Metric Details
Report Name OPO-containing Infant Formulas Market
Accounted market size in 2025 US$ 1117 million
Forecasted market size in 2032 US$ 1564 million
CAGR 5.0%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Cow Milk Formula
  • Goat Milk Formula
by Application
  • 0 - 6 Month
  • 6 - 12 Month
  • 12 - 36 Month
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company BiosTime, Nutriben, Ausnutria, HERDS, Milupa, Shanxi Yatai, Beingmate, Abbott, Brightdairy, Feihe, Wyeth Nutrition, Deloraine, Yili, Kabrita
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for OPO-containing Infant Formulas manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines OPO-containing Infant Formulas sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is OPO-containing Infant Formulas Market growing?

Ans: The OPO-containing Infant Formulas Market witnessing a CAGR of 5.0% during the forecast period 2026-2032.

What is the OPO-containing Infant Formulas Market size in 2032?

Ans: The OPO-containing Infant Formulas Market size in 2032 will be US$ 1564 million.

Who are the main players in the OPO-containing Infant Formulas Market report?

Ans: The main players in the OPO-containing Infant Formulas Market are BiosTime, Nutriben, Ausnutria, HERDS, Milupa, Shanxi Yatai, Beingmate, Abbott, Brightdairy, Feihe, Wyeth Nutrition, Deloraine, Yili, Kabrita

What are the Application segmentation covered in the OPO-containing Infant Formulas Market report?

Ans: The Applications covered in the OPO-containing Infant Formulas Market report are 0 - 6 Month, 6 - 12 Month, 12 - 36 Month

What are the Type segmentation covered in the OPO-containing Infant Formulas Market report?

Ans: The Types covered in the OPO-containing Infant Formulas Market report are Cow Milk Formula, Goat Milk Formula

1 OPO-containing Infant Formulas Market Overview
1.1 Product Definition
1.2 OPO-containing Infant Formulas by Type
1.2.1 Global OPO-containing Infant Formulas Market Value by Type: 2025 vs 2032
1.2.2 Cow Milk Formula
1.2.3 Goat Milk Formula
1.3 OPO-containing Infant Formulas by Application
1.3.1 Global OPO-containing Infant Formulas Market Value by Application: 2025 vs 2032
1.3.2 0 - 6 Month
1.3.3 6 - 12 Month
1.3.4 12 - 36 Month
1.4 Global OPO-containing Infant Formulas Market Size Estimates and Forecasts
1.4.1 Global OPO-containing Infant Formulas Revenue 2021–2032
1.4.2 Global OPO-containing Infant Formulas Sales 2021–2032
1.4.3 Global OPO-containing Infant Formulas Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 OPO-containing Infant Formulas Market Competition by Manufacturers
2.1 Global OPO-containing Infant Formulas Sales Market Share by Manufacturers (2021–2026)
2.2 Global OPO-containing Infant Formulas Revenue Market Share by Manufacturers (2021–2026)
2.3 Global OPO-containing Infant Formulas Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of OPO-containing Infant Formulas, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of OPO-containing Infant Formulas, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of OPO-containing Infant Formulas, Product Types and Applications
2.7 Global Key Manufacturers of OPO-containing Infant Formulas, Date of Entry into the Industry
2.8 Global OPO-containing Infant Formulas Market Competitive Situation and Trends
2.8.1 Global OPO-containing Infant Formulas Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global OPO-containing Infant Formulas Players Market Share by Revenue
2.8.3 Global OPO-containing Infant Formulas Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global OPO-containing Infant Formulas Market Scenario by Region
3.1 Global OPO-containing Infant Formulas Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global OPO-containing Infant Formulas Sales by Region: 2021–2032
3.2.1 Global OPO-containing Infant Formulas Sales by Region: 2021–2026
3.2.2 Global OPO-containing Infant Formulas Sales by Region: 2027–2032
3.3 Global OPO-containing Infant Formulas Revenue by Region: 2021–2032
3.3.1 Global OPO-containing Infant Formulas Revenue by Region: 2021–2026
3.3.2 Global OPO-containing Infant Formulas Revenue by Region: 2027–2032
3.4 North America OPO-containing Infant Formulas Market Facts & Figures by Country
3.4.1 North America OPO-containing Infant Formulas Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America OPO-containing Infant Formulas Sales by Country (2021–2032)
3.4.3 North America OPO-containing Infant Formulas Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe OPO-containing Infant Formulas Market Facts & Figures by Country
3.5.1 Europe OPO-containing Infant Formulas Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe OPO-containing Infant Formulas Sales by Country (2021–2032)
3.5.3 Europe OPO-containing Infant Formulas Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific OPO-containing Infant Formulas Market Facts & Figures by Region
3.6.1 Asia Pacific OPO-containing Infant Formulas Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific OPO-containing Infant Formulas Sales by Region (2021–2032)
3.6.3 Asia Pacific OPO-containing Infant Formulas Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Southeast Asia
3.6.10 Vietnam
3.7 Latin America OPO-containing Infant Formulas Market Facts & Figures by Country
3.7.1 Latin America OPO-containing Infant Formulas Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America OPO-containing Infant Formulas Sales by Country (2021–2032)
3.7.3 Latin America OPO-containing Infant Formulas Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa OPO-containing Infant Formulas Market Facts & Figures by Country
3.8.1 Middle East and Africa OPO-containing Infant Formulas Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa OPO-containing Infant Formulas Sales by Country (2021–2032)
3.8.3 Middle East and Africa OPO-containing Infant Formulas Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global OPO-containing Infant Formulas Sales by Type (2021–2032)
4.1.1 Global OPO-containing Infant Formulas Sales by Type (2021–2026)
4.1.2 Global OPO-containing Infant Formulas Sales by Type (2027–2032)
4.1.3 Global OPO-containing Infant Formulas Sales Market Share by Type (2021–2032)
4.2 Global OPO-containing Infant Formulas Revenue by Type (2021–2032)
4.2.1 Global OPO-containing Infant Formulas Revenue by Type (2021–2026)
4.2.2 Global OPO-containing Infant Formulas Revenue by Type (2027–2032)
4.2.3 Global OPO-containing Infant Formulas Revenue Market Share by Type (2021–2032)
4.3 Global OPO-containing Infant Formulas Price by Type (2021–2032)
5 Segment by Application
5.1 Global OPO-containing Infant Formulas Sales by Application (2021–2032)
5.1.1 Global OPO-containing Infant Formulas Sales by Application (2021–2026)
5.1.2 Global OPO-containing Infant Formulas Sales by Application (2027–2032)
5.1.3 Global OPO-containing Infant Formulas Sales Market Share by Application (2021–2032)
5.2 Global OPO-containing Infant Formulas Revenue by Application (2021–2032)
5.2.1 Global OPO-containing Infant Formulas Revenue by Application (2021–2026)
5.2.2 Global OPO-containing Infant Formulas Revenue by Application (2027–2032)
5.2.3 Global OPO-containing Infant Formulas Revenue Market Share by Application (2021–2032)
5.3 Global OPO-containing Infant Formulas Price by Application (2021–2032)
6 Key Companies Profiled
6.1 BiosTime
6.1.1 BiosTime Company Information
6.1.2 BiosTime Description and Business Overview
6.1.3 BiosTime OPO-containing Infant Formulas Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 BiosTime OPO-containing Infant Formulas Product Portfolio
6.1.5 BiosTime Recent Developments/Updates
6.2 Nutriben
6.2.1 Nutriben Company Information
6.2.2 Nutriben Description and Business Overview
6.2.3 Nutriben OPO-containing Infant Formulas Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Nutriben OPO-containing Infant Formulas Product Portfolio
6.2.5 Nutriben Recent Developments/Updates
6.3 Ausnutria
6.3.1 Ausnutria Company Information
6.3.2 Ausnutria Description and Business Overview
6.3.3 Ausnutria OPO-containing Infant Formulas Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Ausnutria OPO-containing Infant Formulas Product Portfolio
6.3.5 Ausnutria Recent Developments/Updates
6.4 HERDS
6.4.1 HERDS Company Information
6.4.2 HERDS Description and Business Overview
6.4.3 HERDS OPO-containing Infant Formulas Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 HERDS OPO-containing Infant Formulas Product Portfolio
6.4.5 HERDS Recent Developments/Updates
6.5 Milupa
6.5.1 Milupa Company Information
6.5.2 Milupa Description and Business Overview
6.5.3 Milupa OPO-containing Infant Formulas Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Milupa OPO-containing Infant Formulas Product Portfolio
6.5.5 Milupa Recent Developments/Updates
6.6 Shanxi Yatai
6.6.1 Shanxi Yatai Company Information
6.6.2 Shanxi Yatai Description and Business Overview
6.6.3 Shanxi Yatai OPO-containing Infant Formulas Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Shanxi Yatai OPO-containing Infant Formulas Product Portfolio
6.6.5 Shanxi Yatai Recent Developments/Updates
6.7 Beingmate
6.7.1 Beingmate Company Information
6.7.2 Beingmate Description and Business Overview
6.7.3 Beingmate OPO-containing Infant Formulas Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Beingmate OPO-containing Infant Formulas Product Portfolio
6.7.5 Beingmate Recent Developments/Updates
6.8 Abbott
6.8.1 Abbott Company Information
6.8.2 Abbott Description and Business Overview
6.8.3 Abbott OPO-containing Infant Formulas Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Abbott OPO-containing Infant Formulas Product Portfolio
6.8.5 Abbott Recent Developments/Updates
6.9 Brightdairy
6.9.1 Brightdairy Company Information
6.9.2 Brightdairy Description and Business Overview
6.9.3 Brightdairy OPO-containing Infant Formulas Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Brightdairy OPO-containing Infant Formulas Product Portfolio
6.9.5 Brightdairy Recent Developments/Updates
6.10 Feihe
6.10.1 Feihe Company Information
6.10.2 Feihe Description and Business Overview
6.10.3 Feihe OPO-containing Infant Formulas Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Feihe OPO-containing Infant Formulas Product Portfolio
6.10.5 Feihe Recent Developments/Updates
6.11 Wyeth Nutrition
6.11.1 Wyeth Nutrition Company Information
6.11.2 Wyeth Nutrition Description and Business Overview
6.11.3 Wyeth Nutrition OPO-containing Infant Formulas Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Wyeth Nutrition OPO-containing Infant Formulas Product Portfolio
6.11.5 Wyeth Nutrition Recent Developments/Updates
6.12 Deloraine
6.12.1 Deloraine Company Information
6.12.2 Deloraine Description and Business Overview
6.12.3 Deloraine OPO-containing Infant Formulas Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Deloraine OPO-containing Infant Formulas Product Portfolio
6.12.5 Deloraine Recent Developments/Updates
6.13 Yili
6.13.1 Yili Company Information
6.13.2 Yili Description and Business Overview
6.13.3 Yili OPO-containing Infant Formulas Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Yili OPO-containing Infant Formulas Product Portfolio
6.13.5 Yili Recent Developments/Updates
6.14 Kabrita
6.14.1 Kabrita Company Information
6.14.2 Kabrita Description and Business Overview
6.14.3 Kabrita OPO-containing Infant Formulas Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Kabrita OPO-containing Infant Formulas Product Portfolio
6.14.5 Kabrita Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 OPO-containing Infant Formulas Industry Chain Analysis
7.2 OPO-containing Infant Formulas Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 OPO-containing Infant Formulas Production Mode & Process Analysis
7.4 OPO-containing Infant Formulas Sales and Marketing
7.4.1 OPO-containing Infant Formulas Sales Channels
7.4.2 OPO-containing Infant Formulas Distributors
7.5 OPO-containing Infant Formulas Customer Analysis
8 OPO-containing Infant Formulas Market Dynamics
8.1 OPO-containing Infant Formulas Industry Trends
8.2 OPO-containing Infant Formulas Market Drivers
8.3 OPO-containing Infant Formulas Market Challenges
8.4 OPO-containing Infant Formulas Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global OPO-containing Infant Formulas Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global OPO-containing Infant Formulas Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global OPO-containing Infant Formulas Market Competitive Situation by Manufacturers in 2025
 Table 4. Global OPO-containing Infant Formulas Sales (K MT) of Key Manufacturers (2021–2026)
 Table 5. Global OPO-containing Infant Formulas Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global OPO-containing Infant Formulas Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global OPO-containing Infant Formulas Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market OPO-containing Infant Formulas Average Price (USD/MT) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of OPO-containing Infant Formulas, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of OPO-containing Infant Formulas, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of OPO-containing Infant Formulas, Product Types and Applications
 Table 12. Global Key Manufacturers of OPO-containing Infant Formulas, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global OPO-containing Infant Formulas Companies by Tier (Tier 1, Tier 2, Tier 3), based on OPO-containing Infant Formulas Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global OPO-containing Infant Formulas Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global OPO-containing Infant Formulas Sales by Region (K MT), 2021–2026
 Table 18. Global OPO-containing Infant Formulas Sales Market Share by Region (2021–2026)
 Table 19. Global OPO-containing Infant Formulas Sales by Region (K MT), 2027–2032
 Table 20. Global OPO-containing Infant Formulas Sales Market Share by Region (2027–2032)
 Table 21. Global OPO-containing Infant Formulas Revenue by Region (US$ Million), 2021–2026
 Table 22. Global OPO-containing Infant Formulas Revenue Market Share by Region (2021–2026)
 Table 23. Global OPO-containing Infant Formulas Revenue by Region (US$ Million), 2027–2032
 Table 24. Global OPO-containing Infant Formulas Revenue Market Share by Region (2027–2032)
 Table 25. North America OPO-containing Infant Formulas Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America OPO-containing Infant Formulas Sales by Country (K MT), 2021–2026
 Table 27. North America OPO-containing Infant Formulas Sales by Country (K MT), 2027–2032
 Table 28. North America OPO-containing Infant Formulas Revenue by Country (US$ Million), 2021–2026
 Table 29. North America OPO-containing Infant Formulas Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe OPO-containing Infant Formulas Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe OPO-containing Infant Formulas Sales by Country (K MT), 2021–2026
 Table 32. Europe OPO-containing Infant Formulas Sales by Country (K MT), 2027–2032
 Table 33. Europe OPO-containing Infant Formulas Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe OPO-containing Infant Formulas Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific OPO-containing Infant Formulas Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific OPO-containing Infant Formulas Sales by Region (K MT), 2021–2026
 Table 37. Asia Pacific OPO-containing Infant Formulas Sales by Region (K MT), 2027–2032
 Table 38. Asia Pacific OPO-containing Infant Formulas Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific OPO-containing Infant Formulas Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America OPO-containing Infant Formulas Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America OPO-containing Infant Formulas Sales by Country (K MT), 2021–2026
 Table 42. Latin America OPO-containing Infant Formulas Sales by Country (K MT), 2027–2032
 Table 43. Latin America OPO-containing Infant Formulas Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America OPO-containing Infant Formulas Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa OPO-containing Infant Formulas Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa OPO-containing Infant Formulas Sales by Country (K MT), 2021–2026
 Table 47. Middle East and Africa OPO-containing Infant Formulas Sales by Country (K MT), 2027–2032
 Table 48. Middle East and Africa OPO-containing Infant Formulas Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa OPO-containing Infant Formulas Revenue by Country (US$ Million), 2027–2032
 Table 50. Global OPO-containing Infant Formulas Sales (K MT) by Type (2021–2026)
 Table 51. Global OPO-containing Infant Formulas Sales (K MT) by Type (2027–2032)
 Table 52. Global OPO-containing Infant Formulas Sales Market Share by Type (2021–2026)
 Table 53. Global OPO-containing Infant Formulas Sales Market Share by Type (2027–2032)
 Table 54. Global OPO-containing Infant Formulas Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global OPO-containing Infant Formulas Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global OPO-containing Infant Formulas Revenue Market Share by Type (2021–2026)
 Table 57. Global OPO-containing Infant Formulas Revenue Market Share by Type (2027–2032)
 Table 58. Global OPO-containing Infant Formulas Price (USD/MT) by Type (2021–2026)
 Table 59. Global OPO-containing Infant Formulas Price (USD/MT) by Type (2027–2032)
 Table 60. Global OPO-containing Infant Formulas Sales (K MT) by Application (2021–2026)
 Table 61. Global OPO-containing Infant Formulas Sales (K MT) by Application (2027–2032)
 Table 62. Global OPO-containing Infant Formulas Sales Market Share by Application (2021–2026)
 Table 63. Global OPO-containing Infant Formulas Sales Market Share by Application (2027–2032)
 Table 64. Global OPO-containing Infant Formulas Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global OPO-containing Infant Formulas Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global OPO-containing Infant Formulas Revenue Market Share by Application (2021–2026)
 Table 67. Global OPO-containing Infant Formulas Revenue Market Share by Application (2027–2032)
 Table 68. Global OPO-containing Infant Formulas Price (USD/MT) by Application (2021–2026)
 Table 69. Global OPO-containing Infant Formulas Price (USD/MT) by Application (2027–2032)
 Table 70. BiosTime Company Information
 Table 71. BiosTime Description and Business Overview
 Table 72. BiosTime OPO-containing Infant Formulas Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
 Table 73. BiosTime OPO-containing Infant Formulas Product
 Table 74. BiosTime Recent Developments/Updates
 Table 75. Nutriben Company Information
 Table 76. Nutriben Description and Business Overview
 Table 77. Nutriben OPO-containing Infant Formulas Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
 Table 78. Nutriben OPO-containing Infant Formulas Product
 Table 79. Nutriben Recent Developments/Updates
 Table 80. Ausnutria Company Information
 Table 81. Ausnutria Description and Business Overview
 Table 82. Ausnutria OPO-containing Infant Formulas Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
 Table 83. Ausnutria OPO-containing Infant Formulas Product
 Table 84. Ausnutria Recent Developments/Updates
 Table 85. HERDS Company Information
 Table 86. HERDS Description and Business Overview
 Table 87. HERDS OPO-containing Infant Formulas Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
 Table 88. HERDS OPO-containing Infant Formulas Product
 Table 89. HERDS Recent Developments/Updates
 Table 90. Milupa Company Information
 Table 91. Milupa Description and Business Overview
 Table 92. Milupa OPO-containing Infant Formulas Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
 Table 93. Milupa OPO-containing Infant Formulas Product
 Table 94. Milupa Recent Developments/Updates
 Table 95. Shanxi Yatai Company Information
 Table 96. Shanxi Yatai Description and Business Overview
 Table 97. Shanxi Yatai OPO-containing Infant Formulas Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
 Table 98. Shanxi Yatai OPO-containing Infant Formulas Product
 Table 99. Shanxi Yatai Recent Developments/Updates
 Table 100. Beingmate Company Information
 Table 101. Beingmate Description and Business Overview
 Table 102. Beingmate OPO-containing Infant Formulas Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
 Table 103. Beingmate OPO-containing Infant Formulas Product
 Table 104. Beingmate Recent Developments/Updates
 Table 105. Abbott Company Information
 Table 106. Abbott Description and Business Overview
 Table 107. Abbott OPO-containing Infant Formulas Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
 Table 108. Abbott OPO-containing Infant Formulas Product
 Table 109. Abbott Recent Developments/Updates
 Table 110. Brightdairy Company Information
 Table 111. Brightdairy Description and Business Overview
 Table 112. Brightdairy OPO-containing Infant Formulas Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
 Table 113. Brightdairy OPO-containing Infant Formulas Product
 Table 114. Brightdairy Recent Developments/Updates
 Table 115. Feihe Company Information
 Table 116. Feihe Description and Business Overview
 Table 117. Feihe OPO-containing Infant Formulas Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
 Table 118. Feihe OPO-containing Infant Formulas Product
 Table 119. Feihe Recent Developments/Updates
 Table 120. Wyeth Nutrition Company Information
 Table 121. Wyeth Nutrition Description and Business Overview
 Table 122. Wyeth Nutrition OPO-containing Infant Formulas Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
 Table 123. Wyeth Nutrition OPO-containing Infant Formulas Product
 Table 124. Wyeth Nutrition Recent Developments/Updates
 Table 125. Deloraine Company Information
 Table 126. Deloraine Description and Business Overview
 Table 127. Deloraine OPO-containing Infant Formulas Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
 Table 128. Deloraine OPO-containing Infant Formulas Product
 Table 129. Deloraine Recent Developments/Updates
 Table 130. Yili Company Information
 Table 131. Yili Description and Business Overview
 Table 132. Yili OPO-containing Infant Formulas Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
 Table 133. Yili OPO-containing Infant Formulas Product
 Table 134. Yili Recent Developments/Updates
 Table 135. Kabrita Company Information
 Table 136. Kabrita Description and Business Overview
 Table 137. Kabrita OPO-containing Infant Formulas Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
 Table 138. Kabrita OPO-containing Infant Formulas Product
 Table 139. Kabrita Recent Developments/Updates
 Table 140. Key Raw Materials Lists
 Table 141. Raw Materials Key Suppliers Lists
 Table 142. OPO-containing Infant Formulas Distributors List
 Table 143. OPO-containing Infant Formulas Customers List
 Table 144. OPO-containing Infant Formulas Market Trends
 Table 145. OPO-containing Infant Formulas Market Drivers
 Table 146. OPO-containing Infant Formulas Market Challenges
 Table 147. OPO-containing Infant Formulas Market Restraints
 Table 148. Research Programs/Design for This Report
 Table 149. Key Data Information from Secondary Sources
 Table 150. Key Data Information from Primary Sources
 Table 151. Authors List of This Report


List of Figures
 Figure 1. Product Picture of OPO-containing Infant Formulas
 Figure 2. Global OPO-containing Infant Formulas Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global OPO-containing Infant Formulas Market Share by Type: 2025 & 2032
 Figure 4. Cow Milk Formula Product Picture
 Figure 5. Goat Milk Formula Product Picture
 Figure 6. Global OPO-containing Infant Formulas Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global OPO-containing Infant Formulas Market Share by Application: 2025 & 2032
 Figure 8. 0 - 6 Month
 Figure 9. 6 - 12 Month
 Figure 10. 12 - 36 Month
 Figure 11. Global OPO-containing Infant Formulas Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 12. Global OPO-containing Infant Formulas Market Size (US$ Million), 2021–2032
 Figure 13. Global OPO-containing Infant Formulas Sales (K MT), 2021–2032
 Figure 14. Global OPO-containing Infant Formulas Average Price (USD/MT), 2021–2032
 Figure 15. OPO-containing Infant Formulas Report Years Considered
 Figure 16. OPO-containing Infant Formulas Sales Share by Manufacturers in 2025
 Figure 17. Global OPO-containing Infant Formulas Revenue Share by Manufacturers in 2025
 Figure 18. Top 5 and Top 10 Global OPO-containing Infant Formulas Players: Market Share by Revenue in OPO-containing Infant Formulas in 2025
 Figure 19. OPO-containing Infant Formulas Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 20. Global OPO-containing Infant Formulas Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 21. North America OPO-containing Infant Formulas Sales Market Share by Country (2021–2032)
 Figure 22. North America OPO-containing Infant Formulas Revenue Market Share by Country (2021–2032)
 Figure 23. U.S. OPO-containing Infant Formulas Revenue Growth Rate (US$ Million), 2021–2032
 Figure 24. Canada OPO-containing Infant Formulas Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Europe OPO-containing Infant Formulas Sales Market Share by Country (2021–2032)
 Figure 26. Europe OPO-containing Infant Formulas Revenue Market Share by Country (2021–2032)
 Figure 27. Germany OPO-containing Infant Formulas Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. France OPO-containing Infant Formulas Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. U.K. OPO-containing Infant Formulas Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Italy OPO-containing Infant Formulas Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Russia OPO-containing Infant Formulas Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Asia Pacific OPO-containing Infant Formulas Sales Market Share by Region (2021–2032)
 Figure 33. Asia Pacific OPO-containing Infant Formulas Revenue Market Share by Region (2021–2032)
 Figure 34. China OPO-containing Infant Formulas Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Japan OPO-containing Infant Formulas Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. South Korea OPO-containing Infant Formulas Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. India OPO-containing Infant Formulas Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Australia OPO-containing Infant Formulas Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Southeast Asia OPO-containing Infant Formulas Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Vietnam OPO-containing Infant Formulas Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Latin America OPO-containing Infant Formulas Sales Market Share by Country (2021–2032)
 Figure 42. Latin America OPO-containing Infant Formulas Revenue Market Share by Country (2021–2032)
 Figure 43. Mexico OPO-containing Infant Formulas Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Brazil OPO-containing Infant Formulas Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Argentina OPO-containing Infant Formulas Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Middle East and Africa OPO-containing Infant Formulas Sales Market Share by Country (2021–2032)
 Figure 47. Middle East and Africa OPO-containing Infant Formulas Revenue Market Share by Country (2021–2032)
 Figure 48. Turkey OPO-containing Infant Formulas Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Saudi Arabia OPO-containing Infant Formulas Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. U.A.E OPO-containing Infant Formulas Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Global Sales Market Share of OPO-containing Infant Formulas by Type (2021–2032)
 Figure 52. Global Revenue Market Share of OPO-containing Infant Formulas by Type (2021–2032)
 Figure 53. Global OPO-containing Infant Formulas Price (USD/MT) by Type (2021–2032)
 Figure 54. Global Sales Market Share of OPO-containing Infant Formulas by Application (2021–2032)
 Figure 55. Global Revenue Market Share of OPO-containing Infant Formulas by Application (2021–2032)
 Figure 56. Global OPO-containing Infant Formulas Price (USD/MT) by Application (2021–2032)
 Figure 57. OPO-containing Infant Formulas Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India